Nuveen, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Nuveen, LLC holds 59,978 shares of ARCT stock, worth $714,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,978Holding current value
$714,937% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
162Shares Held
25.9MCall Options Held
139KPut Options Held
149K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$56 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$23.9 Million0.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.93MShares$23 Million0.01% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$23 Million0.27% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $317M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...